Drug interactions and the anesthesiologist;Medikamenteninteraktionen für den anästhesisten

Anaesthesist

Volumn 52, Issue 9, 2003, Pages 839-857

  Milde, A S ^a   Motsch, J ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Anesthesia; Drug interactions; Incidence; Mechanism; Pharmacodynamic; Pharmacokinetic; Risk factors

Indexed keywords

AMINOGLYCOSIDE; AMLODIPINE; ANESTHETIC AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CORTICOSTEROID; CYCLOSPORIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FELODIPINE; FUROSEMIDE; GALLOPAMIL; HALOPERIDOL; ISRADIPINE; LINCOMYCIN; MONOAMINE OXIDASE INHIBITOR; NICARDIPINE; NIFEDIPINE; OMEPRAZOLE; PANCURONIUM; PENICILLIN G; PETHIDINE; SEROTONIN UPTAKE INHIBITOR; SUXAMETHONIUM; THIOPENTAL; UNINDEXED DRUG; VECURONIUM; VERAPAMIL;

ANESTHESIA; ANESTHESIST; DEPRESSION; DRUG EFFECT; DRUG FATALITY; DRUG MECHANISM; HUMAN; HYPERTENSION; INCIDENCE; PARKINSON DISEASE; POLYPHARMACY; REVIEW; RISK FACTOR; SIDE EFFECT;

ANESTHETICS; DRUG INCOMPATIBILITY; DRUG INTERACTIONS; HUMANS; PHARMACOKINETICS;

EID: 0141637270     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-003-0563-2     Document Type: Review

References (78)

1. Ahonen J, Olkkola KT, Salmenpera M et al. (1996) Effect of diltiazem on midazolam and alfentanil disposition in patients undergoing coronary artery bypass grafting. Anesthesiolgy 85:1246-1252
2. Ang-Lee MK, Moss J, Yuan CS (2001) Herbal medicines and perioperative care. JAMA 286:208-216
3. Andersen V, Pedersen N, Larsen NE et al. (2002) Intestinal first pass metabolism of midazolam in liver cirrhosis - effect of grapefruit juice. Br J Clin Pharmacol 54:120-124
4. Bailey DG, Spence M, Spence A et al. (1998) Grapefruit juice-drug interactions. Br J Clin Pharmacol 46:101
5. Baillard C, Gehan G, Reboul-Marty J et al. (2000) Residual curarization in the recovery room after vecuronium. Br J Anaesth 84:394-395
6. Berenbaum MC (1989) What is synergy? Pharmacol Rev 41:93-141
7. Berg H, Viby-Mogensen J, Roed J et al. (1997) Residual neuromuscular block is a risk factor for postoperative pulmonary complications. Acta Anaesthesiol Scand 41:1095-1103
8. Bodner RA, Lynch T, Lewis L et al. (1995) Serotonin syndrome. Neurology 45:219-223
9. Bouillon T, Bruhn J, Radu-Radulescu R et al. (2002) Non-steady state analysis of the pharmacokinetic interaction between propofol and remifentanil. Anesthesiology 97:1350-1362
10. Bovill JG (1997) Adverse drug interactions in a nesthesia. J Clin Anesth 9:3S-13S
11. Bovill JG (2002) Drug interactions. IARS Review Course Lectures, pp 17-21
12. Breidenbach T, Hoffmann MW, Becker T et al. (2000) Drug interaction of St. John's wort with cyclosporine. Lancet 355:1912
13. Cammu G (2001) Interactions of neuromuscular blocking drugs. Acta Anaesth Belg 52:357-363
14. Coriat P, Richer C, Douraki T et al. (1994) Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 81:299-307
15. Court MH, Duan SX, Hesse LM et al. (2001) Cytochrome p-450 2B6 is responsible of interindividual variability of propofol hydroxylation by human liver microsomes. Anesthesiology 94:110-119
16. Davis AW, Heavner JE (2002) Polypharmacy, age and scheduled surgery. J Clin Anesth 14:329-334
17. Dobrev D, Milde AS, Andreas K et al. (1999) The effect of verapamil and diltiazem on N-, P- and Q-Type calcium channels mediating dopamine release in rat striatum. Br J Pharmacol 127:576-582
18. Eichler A, Eiden U, Kessler P (2000) Aids und Anästhesie. Anaesthesist 49:1006-1017
19. Erkola O, Rautoma P, Meretoja OA (1996) Mivarurium when preceded by pancuronium becomes a long-acting muscle relaxant. Anesthesiology 84:562-565
20. Eschenhagen T (2000) Overview of drug interactions. Combining drugs correctly! MMW Fortschr Med 142:28-33
21. Favetta P, Degoute CS, Perdrix JP et al. (2002) Propofol metabolites in man following propofol induction and maintenance. Br J Anaesth 88:653-658
22. Feierman DE (2000) The effect of paracetamol (acetaminophen) on fentanyl metabolism in vitro. Acta Anaesth Scan 44:560-563
23. Feierman DE, Lasker JM (1996) Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes: role of CYP3A4. Drug Metab Dispos 24:932-939
24. Fuchs-Buder T, Mencke T (2001) Neuromuskuläres Monitoring. Anaesthesist 50:129-138
25. Goho C (2001) Oral midazolam-grapefruit juice interaction. Pediatr Dent 23:365-366
26. Grandison MK, Boudinot FD (2000) Age related changes in protein binding of drugs: implications for therapy. Clin Pharmacokinet 38:271-290
27. Graudins A, Dowsett RP, Liddle C (2002) The toxicity of antidepressant poisoning: is it changing? A comparative study of cyclic and newer serotonin-speciflc antidepressants. Emerg Med 14:440-446
28. Hodges PJ, Kam PC (2002) The perioperative implications of gerbal medicines. Anaesthesia 57:889-899
29. Janicki PK, James FHM, Erskine WAR et al. (1992) Propofol inhibits enzymatic degradation of alfentanil and sufentanil by isolated liver microsomes in vitro. Br J Anaesth 68:311-312
30. Kam PC, Chang GW (1997) Selective serotonin reuptake inhibitors. Pharmacology and clinical implications in anesthesia and critical care medicine. Anaesthesia 52:982-988
31. Kennedy JM, van Rij AM, Spears GF et al. (2000) Polypharmacy in a general surgical unit and consequences of drug withdrawal. Br J Clin Pharmacol 49:353-362
32. Kharasch ED, Hlankins DC, Cox K (1999) Clinical isoflurane metabolism by cytochrome P450 2E1. Anesthesiolgy 90:766-771
33. Kharasch ED, Russell M, Mautz D et al. (1997) The role of cytochrome P450 3A4 in alfentanil clearance. Anesthesiolgy 87:36-50
34. Kharasch ED, Thummel KE, Mautz D et al. (1994) Clinical enflurane metabolism by cytochrome P450 2E1. J Clin Pharmacol Ther 55:434-440
35. Kharasch ED, Thummel KE (1993) Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane and methoxyfl urane. Anesthesiolgy 79:795-807
36. Kim DW, Joshi GP, White PF et al. (1996) Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia. Anesth Analg 83:818-822
37. Kim KS, Chun YS, Chon SU et al. (1998) Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination. Anesthesiology 53:872-878
38. Kindler CH, Verotta D, Gray AT et al. (2000) Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium. Anesthesiology 92:821-832
39. Kisch-Wedel H, Thiel M (2002) Anästhesie bei allergischer Diathese. Anaesthesist 51:868-881
40. Kitteringham NR, Pirmohamed M, Park BK et al. (1998) The pharmacology of the cytochrome p450 enzyme system. Baillères Clin Anaesthesiol 12:191-211
41. Kotlyar M, Carson SW (1999) Effects of obesity on the cytochrome P450 enzyme system. Int J Clin Pharmacol Ther 37:8-19
42. Lagasse RS (2002) Anesthesia safety: model or myth? Anesthesiolgy 97:1609-1617
43. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients. JAMA 279:1200-1205
44. Lewis DF (2000) On the recognition of mammalian microsomal cytochrome p450 substrates and their characteristics. Biochem Pharmacol 60:293-306
45. Lohr JW, Willsky GR, Acara MA (1998) Renal drug metabolism. Pharmacol Rev 50:107-141
46. McDonald TF, Pelzer S, Trautwein W et al. (1994) Regulation and modulation of calcium channels in cardiac skeletal and smooth muscle cells. Physiol Rev 74:365-507
47. Meistelman C (2001) Update on neuromuscular pharmacology. Curr Opin Anaesthesiol 14:399-404
48. Merin RG (1987) Calcium channel blocking drugs and anesthetics: is the drug interaction beneficial or detrimental? Anesthesiolgy 66:111-113
49. Mertens MJ, Vuyk J, Olofsen E et al. (2001) Propofol alters the pharmacokinetics of alfentanil in healthy male volunteers. Anesthesiolgy 94:949-957
50. Miller ED, Longnecker DE, Peach MJ (1978) The regulatory function of the renin-angiotensin system during general anesthesia. Anesthesiology 48:399-403
51. Minto CF, Schnider TW, Short TG et al. (2000) Response surface model for anesthetic drug interactions. Anesthesiology 92:1603-1616
52. Nielsen-Kudsk JE, Buhl JS, Johannessen AC (1990) Verapamil-induced inhibition of theophylline elimination in healthy humans. Pharmacol Toxicol 66:101-103
53. Niemann CU, Stabernack C, Serkova N et al. (2002) Cyclosporine can increase isoflurane MAC. Anesth Analg 95:930-934
54. Nishiyama T, Misawa K, Yokoyama T et al. (2002) Effects of combining midazolam and barbiturate on the response to tracheal intubation: changes in autonomic nervous system. J Clin Anesth 14:344-348
55. Olkkola KT, Ahonen J (2001) Drug interactions. Curr Opin Anesth 14:411-416
56. Orme R, Leslie K, Umranikar A et al. (2002) Esmolol and anesthetic requirement for loss of responsiveness during propofol anesthesia. Anesth Analg 93:112-116
57. Paul M, Fokt RM, Kindler CH et al. (2002) Characterization of the interactions between volatile anesthetics and neuromuscular blockers at the muscle nicotinic acetylcholine receptor. Anesth Analg 95:362-367
58. 450-Enzyme und ihre Bedeutung for Medika menteninteraktionen. Anaesthesist 51:2-15
59. Power BM, Pinder M, Hackett LP et al. (1995) Fatal serotonin syndrome following a combined overdose of moclobemide, domipramine and fluoxetine. Anaesth Int Care 23:499-502
60. Rosow CE (1997) Anesthetic drug interaction: an overview. J Clin Anesth 9:275-32S
61. Roth A, Angster R, Forst H (1999) Begleitmedikation. Anaesthesist 48:267-283
62. Ruschitzka F, Meier PJ, Turina M et al. (2000) Acute heart transplant rejection due to Saint John's wort. Lancet 355:548-549
63. Seagar M, Lëvěque C, Charvin N et al. (1999) Interactions between proteins implicated in exocytosis and voltage-gated calcium channels. Phil Trans R Soc Lond B 354:289-297
64. Sekerci S, Tulunay M (1996) Interactions of calcium channel blockers with non-depolarising muscle relaxants in vitro. Anaesthesia 51:140-144
65. Shapiro LE, Shear NH (2002) Drug interactions: proteins, pumps, and p-450s. J Am Acad Dermatol 47:467-484
66. Singh YN, Johnson A, Lulf LA et al. (1996) Study of in vitro and in vitro effects of isradipine in skeletal muscles and interaction with some drugs. Methods Find Exp Clin Pharmacol 18:499-506
67. Spracklin DK, Hankins DC, Fisher JM et al. (1997) Cytochrome P450 2E1 is the principal catalyst of human halothane metabolism in vitro. J Pharmacol Exp Ther 281:400-411
68. Stovner J, Oftedal N, Holmboe J (1975) The inhibition of cholinesterase by pancuronium. Br J Anaesth 47:949-954
69. Szmuk P, Ezri T, Chelly JE et al. (2000) The onset time of rocuronium is slowed by esmolol and accelerated by ephedrine. Anesth Analg 90:1217-1219
70. Tallarida RJ (2001) Drug synergism: its detection and applications. J Pharmacol Exp Ther 298:865-872
71. Vandemergel X, Beukinga I, Neve P (2000) Serotonin syndrome secondary to the use of sertraline and metoclopramide. Rev Med Brux 21:161-163
72. Veering BT, Burm AG, Feyen HM et al. (2002) Pharmacokinetics of bupivacaine during postoperative epidural infusion. Anesthesiolgy 96:1062-1069
73. Vercauteren MP, Meert TF, Hoffmann VH et al. (2001) Drug interactions in the epidural space. Acta Anaesthesiol Belg 52:437-443
74. Vuyk J (1997) Pharmacokinetic and pharmakodynamic interactions between opioids and propofol. J Clin Anesth 9:23S-265
75. Wali FA (1986) Verapamil intensifies neuromuscular blockade produced by gallamine and pancuronium at the chick neuromuscular junction. Pharmacol Res Commun 18:529-541
76. Wali FA (1986) Interactions of nifedipine and diltiazem with muscle relaxants and reversal of neuromuscular blockade with edrophonium and neostigmine. J Pharmacol 17:244-53
77. Wood M (1991) Pharmacokinetic drug interactions in anaesthetic practice. Clin Pharmacokinet 21:285-307
78. Yatani A, Brown AM (1985) The calcium channel blocker nitrendipin blocks sodium channels in neonatal rat cardiac myocytes. Circ Res 56:868-875